Koivunen Petri, Uhari Matti, Luotonen Jukka, Kristo Aila, Raski Risto, Pokka Tytti, Alho Olli-Pekka
University of Oulu, PO Box 5000, FIN-90014, Finland.
BMJ. 2004 Feb 28;328(7438):487. doi: 10.1136/bmj.37972.678345.0D. Epub 2004 Feb 9.
To evaluate the efficacy of adenoidectomy compared with long term chemoprophylaxis and placebo in the prevention of recurrent acute otitis media in children aged between 10 months and 2 years.
Randomised, double blind, controlled trial.
Oulu University Hospital, a tertiary centre in Finland.
180 children aged 10 months to 2 years with recurrent acute otitis media.
Adenoidectomy, sulfafurazole (sulphisoxazole) 50 mg/kg body weight, given once a day for six months or placebo. Follow up lasted for two years, during which time all symptoms and episodes of acute otitis media were recorded.
Intervention failure (two episodes in two months or three in six months or persistent effusion) during follow up, number of episodes of acute otitis media, number of visits to a doctor because of any infection, and antibiotic prescriptions Number of prescriptions, and days with symptoms of respiratory infection.
Compared with placebo, interventions failed during both the first six months and the rest of the follow up period of 24 months similarly in the adenoidectomy and chemoprophylaxis groups (at six months the differences in risk were 10% (95% confidence interval -9% to 29%) and 18% (-2% to 38%), respectively). No significant differences were observed between the groups in the numbers of episodes of acute otitis media, visits to a doctor, antibiotic prescriptions, and days with symptoms of respiratory infection.
Adenoidectomy, as the first surgical treatment of children aged 10 to 24 months with recurrent acute otitis media, is not effective in preventing further episodes. It cannot be recommended as the primary method of prophylaxis.
评估腺样体切除术与长期化学预防及安慰剂相比,在预防10个月至2岁儿童复发性急性中耳炎方面的疗效。
随机、双盲、对照试验。
芬兰的三级医疗中心奥卢大学医院。
180名年龄在10个月至2岁之间患有复发性急性中耳炎的儿童。
腺样体切除术、磺胺异恶唑50mg/kg体重,每日一次,持续六个月或安慰剂。随访持续两年,在此期间记录所有急性中耳炎的症状和发作情况。
随访期间的干预失败(两个月内发作两次或六个月内发作三次或持续性积液)、急性中耳炎发作次数、因任何感染就诊次数、抗生素处方数量、处方数量以及有呼吸道感染症状的天数。
与安慰剂相比,腺样体切除术组和化学预防组在随访的前六个月以及剩余的24个月期间干预失败情况相似(六个月时风险差异分别为10%(95%置信区间-9%至29%)和18%(-2%至38%))。两组在急性中耳炎发作次数、就诊次数、抗生素处方数量以及有呼吸道感染症状的天数方面未观察到显著差异。
腺样体切除术作为10至24个月患有复发性急性中耳炎儿童的首选手术治疗方法,在预防进一步发作方面无效。不能推荐将其作为主要的预防方法。